objectivespecif
appropri
person
protect
equip
respiratori
protect
influenza
somewhat
controversi
clinic
environ
filter
facepiec
respir
ffr
often
recommend
respiratori
protect
infecti
aerosol
studi
evalu
abil
ffr
captur
viabl
influenza
aerosol
ffr
model
challeng
aerosol
viabl
influenza
inert
polystyren
latex
particl
continu
flow
rate
liter
per
minut
viru
assay
use
madindarbi
canin
kidney
cell
determin
median
tissu
cultur
infect
dose
tcid
aerosol
gener
use
collison
nebul
contain
influenza
viru
tcid
ml
determin
filtrat
effici
viabl
sampl
perform
upstream
downstream
ffr
ffr
filter
particl
influenza
inert
origin
effici
except
model
statist
signific
differ
filtrat
perform
observ
influenza
inert
particl
similar
size
although
statist
signific
differ
observ
model
compar
flow
rate
differ
signific
protect
safeti
healthapprov
ffr
captur
viabl
influenza
aerosol
well
better
rate
suggest
properli
fit
ffr
reduc
inhal
exposur
airborn
influenza
viru
studi
also
provid
evid
filtrat
effici
base
primarili
particl
size
rather
natur
particl
origin
pandem
influenza
pose
signific
health
threat
intern
commun
novel
strain
emerg
vari
wide
virul
infect
primari
mode
human
transmiss
influenza
direct
contact
inspir
inhal
direct
sprayar
respons
spread
influenza
subject
activ
debat
consequ
specif
appropri
person
protect
equip
ppe
respiratori
protect
influenza
likewis
controversi
directspray
transmiss
surgic
mask
may
appropri
reduc
risk
infect
recommend
protect
aerosol
transmiss
via
inhal
inspir
accord
guidanc
provid
center
diseas
control
prevent
occup
safeti
health
administr
osha
mandat
healthcar
worker
wear
ppe
least
protect
properli
fit
nation
institut
occup
safeti
health
niosh
certifi
filter
facepiec
respir
ffr
expos
inhal
inspir
infecti
aerosol
eg
sever
acut
respiratori
syndrom
tuberculosi
pandem
influenza
use
clinic
set
ffr
sometim
also
clear
sale
food
drug
administr
medic
devic
fluidresist
properti
certifi
niosh
devic
carri
niosh
certif
shown
abil
remov
particl
convent
mostpenetr
particl
size
mpp
larger
smaller
particl
remov
effici
howev
mpp
ffr
employ
electret
media
media
possess
electr
charg
smaller
mechan
use
ffr
remov
particl
air
well
understood
also
well
accept
composit
particl
similar
densiti
affect
particl
captur
effici
thu
viabl
inert
particl
equival
size
mass
remov
filtrat
effici
mani
studi
perform
evalu
filtrat
effici
viabl
microorgan
without
except
show
viabl
microorgan
remov
similar
slightli
greater
rate
inert
particl
size
support
idea
ffr
effect
aerosol
transmiss
need
reevalu
everi
new
diseasecaus
agent
howev
even
consist
knowledg
base
end
user
ffr
still
want
confirm
devic
capabl
remov
actual
infect
agent
interest
found
limit
studi
evalu
ffr
perform
challeng
viabl
influenza
aerosol
zuo
et
al
challeng
ffr
viabl
aerosol
human
adenoviru
serotyp
swine
influenza
abl
obtain
viabl
data
adenoviru
upstream
ffr
borkow
et
al
evalu
antimicrobi
efficaci
copperimpregn
ffr
challeng
viabl
aerosol
result
show
greater
viabl
filtrat
effici
vfe
correl
data
inert
particl
studi
challeng
ffr
model
tabl
viabl
influenza
aerosol
repres
human
respiratori
secret
compar
vfe
inert
particl
filtrat
effici
pfe
flow
rate
influenza
atcc
propag
embryon
chicken
egg
mean
standard
world
health
organ
protocol
viru
titer
determin
median
tissu
cultur
infecti
dose
tcid
assay
use
madindarbi
canin
kidney
cell
atcc
cell
cultur
techniqu
approv
world
health
organ
aerosol
studi
influenza
viru
dilut
concentr
tcid
ml
artifici
saliva
buffer
count
median
diamet
cmd
particl
size
distribut
psd
influenza
aerosol
artifici
saliva
buffer
previous
determin
use
aerodynam
particl
sizer
ap
tsi
five
model
nioshapprov
ffr
model
contain
antimicrobi
compon
glaxosmithklin
gsk
actiprotect
safelif
use
studi
tabl
nonantimicrobi
model
chosen
common
use
healthcar
workplac
antimicrobi
model
select
model
commerci
avail
niosh
approv
model
test
triplic
condit
aerosol
challeng
nioshspecifi
standard
flow
rate
liter
per
minut
lpm
morestrenu
aerosol
challeng
lpm
evalu
ffr
perform
extrem
condit
laboratoryscal
aerosol
tunnel
lsat
figur
use
challeng
ffr
viabl
influenza
inert
bead
complet
descript
lsat
report
elsewher
prior
test
lsat
flush
purifi
air
minut
flow
rate
lpm
independ
test
ffr
condit
ffr
glueseal
sampl
holder
describ
elsewher
secur
lsat
via
stainless
steel
sanitari
fit
ffr
first
challeng
polystyren
latex
bead
thermo
scientif
bead
suspend
steril
water
place
collison
nebul
bgi
oper
psi
gener
aerosol
follow
equilibr
period
altern
upstream
downstream
sampl
collect
use
ap
air
flow
redirect
higheffici
particul
air
hepa
filter
collison
nebul
replac
anoth
collison
nebul
contain
ml
influenza
dilut
concentr
tcid
ml
artifici
saliva
follow
equilibr
period
altern
viabl
sampl
collect
upstream
downstream
port
allglass
imping
ace
glass
contain
ml
serumfre
eagl
minimum
essenti
medium
hyclon
laboratori
supplement
penicillinstreptomycin
mm
lglutamin
sigmaaldrich
use
collect
minim
particl
loss
directli
attach
isokinet
sampl
port
lsat
sampl
initi
open
valv
port
appli
vacuum
sourc
sampl
approxim
lpm
minut
sampl
port
close
vacuum
turn
place
ice
viabl
plate
perform
total
sampl
upstream
downstream
altern
sampl
collect
ffr
follow
run
ffr
remov
hepa
filter
connect
sampl
port
lsat
subsequ
flush
purifi
air
lpm
hour
manomet
use
monitor
pressur
drop
across
filter
run
upstream
downstream
measur
bead
studi
collect
use
data
size
bin
ap
concentr
viabl
viru
log
tcid
per
millilit
extract
collect
upstream
downstream
determin
use
formula
equat
use
determin
total
amount
viru
recov
sampl
imping
volum
sampl
detect
downstream
viabl
data
half
detect
limit
tcid
infecti
dose
unit
viabl
assay
use
calcul
reduct
vfe
ffr
determin
use
equat
pfe
determin
use
equat
pair
test
use
compar
inert
bead
viabl
influenza
filtrat
data
ffr
model
averag
pfe
vfe
valu
flow
rate
compar
use
unpair
test
analysi
varianc
anova
test
bonferroni
posttest
use
compar
data
obtain
antimicrobi
nonantimicrobi
ffr
model
equat
follow
l
viabl
express
unit
log
tcid
per
millilit
v
sampl
volum
viabl
virus
present
l
l
half
detect
limit
equat
dl
downstream
log
tcid
ul
upstream
log
tcid
n
number
determin
equat
u
upstream
particl
concentr
downstream
particl
concentr
averag
upstream
challeng
ffr
replic
tcid
per
liter
air
standard
flow
lpm
paramet
mean
pfe
ffr
model
rang
mean
vfe
rang
tabl
statist
comparison
data
set
demonstr
signific
differ
p
inert
viabl
particl
filtrat
kimberlyclark
model
p
safelif
provid
order
magnitud
higher
filtrat
perform
exceed
niosh
standard
ffr
four
safelif
replic
produc
detect
viru
downstream
high
flow
lpm
paramet
mean
pfe
ffr
model
rang
mean
vfe
rang
tabl
safelif
provid
order
magnitud
higher
filtrat
perform
statist
comparison
data
set
demonstr
signific
differ
inert
viabl
particl
filtrat
kimberlyclark
ffr
p
comparison
perform
lpm
conduct
kimberlyclark
model
demonstr
statist
signific
differ
filtrat
effici
inert
viabl
aerosol
challeng
p
respect
gsk
actiprotect
model
found
demonstr
signific
differ
inert
particl
p
anova
test
demonstr
statist
signific
differ
nonantimicrobi
ffr
model
safelif
gsk
actiprotect
vfe
condit
p
respect
signific
differ
also
observ
pfe
p
respect
signific
differ
found
nonantimicrobi
antimicrobi
ffr
condit
previou
experiment
studi
support
filtrat
theori
demonstr
pfe
increas
particl
size
mpp
possibl
laboratori
set
artifici
gener
influenza
aerosol
near
mpp
ffr
particl
size
rang
approxim
rel
unstabl
unlik
exist
practic
actual
workplac
set
influenza
expel
human
via
respiratori
section
typic
much
larger
approxim
bare
viru
acknowledg
exist
diverg
report
pertain
assess
particlesdroplet
deriv
human
respiratori
secret
maintain
use
particl
justifi
basi
literatur
ffr
model
test
part
studi
yield
equival
vfe
pfe
valu
exceed
tabl
niosh
certif
base
remov
particl
higher
remov
expect
larger
particl
studi
although
determin
statist
signific
differ
pfe
vfe
lpm
kimberlyclark
model
less
consid
meaning
niosh
benchmark
met
actual
protect
driven
differ
fit
leakag
filtrat
perform
thu
statist
analysi
case
instruct
indic
low
variabl
among
replic
measur
obtain
particl
sizer
allow
discrimin
slightli
higher
filtrat
effici
inert
particl
gener
greater
variabl
associ
captur
assay
viabl
biolog
particl
possibl
bia
introduc
studi
method
analysi
inert
viabl
challeng
differ
may
influenc
comparison
vfe
pfe
pfe
determin
use
ap
account
particl
whose
aerodynam
particl
size
rang
contrast
vfe
account
particl
psd
anoth
bia
may
present
sampl
procedur
imping
collect
larger
particl
effici
ffr
particl
like
penetr
ffr
fall
smaller
size
rang
captur
effici
imping
lower
anoth
factor
must
consid
distribut
viabl
particl
within
overal
psd
known
may
introduc
anoth
bia
account
data
consist
valu
report
borkow
et
al
demonstr
reduct
vfe
aerosol
approxim
cmd
contain
viabl
influenza
although
sampl
mean
impact
rather
imping
perform
test
lower
flow
rate
lpm
zuo
et
al
also
provid
data
show
viabl
influenza
remov
airstream
provid
particlecount
data
deriv
viabl
challeng
much
smaller
particl
cmd
less
behav
much
differ
effect
flow
rate
ffr
perform
assess
incorpor
flow
condit
experiment
design
accord
cfr
subpart
k
section
flow
rate
condit
specifi
niosh
evalu
perform
ffr
flow
rate
select
repres
worker
inhal
high
work
rate
howev
peak
inhal
flow
breath
may
greater
lpm
brief
period
time
exacerb
work
intens
increas
reason
also
test
lpm
provid
extrem
challeng
filter
overal
filtrat
number
slightli
lower
higher
flow
rate
tabl
would
expect
particl
smaller
critic
inspect
data
show
actual
differ
filtrat
perform
condit
particl
size
studi
neglig
although
statist
signific
differ
mere
indic
low
variabl
data
set
physic
meaning
distinct
although
antimicrobi
ffr
model
safelif
gsk
actiprotect
demonstr
consider
higher
filtrat
effici
nonantimicrobi
model
provid
significantli
greater
reduct
viabl
penetr
compar
inert
particl
attribut
increas
filtrat
effici
physic
mean
rather
antimicrobi
properti
result
line
observ
borkow
et
al
found
improv
vfe
ffr
impregn
copper
oxid
safelif
filtrat
perform
actual
exce
rate
observ
inert
viabl
particl
gsk
ffr
lack
reduct
vfe
due
antimicrobi
expect
manufactur
claim
antimicrobi
surfac
decontamin
interest
note
gsk
ffr
highest
variabl
vfe
among
ffr
test
tabl
reason
unclear
possibl
citric
acid
present
ffr
interfer
viabl
assay
vfe
lower
pfe
might
suggest
citrat
protect
act
shield
viru
downstream
ffr
addit
research
necessari
isol
mechan
caus
variabl
signific
find
healthcar
worker
data
provid
basi
estim
level
protect
healthcar
worker
expect
respir
exposur
infecti
aerosol
inhal
exposur
receiv
respir
wearer
come
combin
leakag
around
face
seal
direct
penetr
filter
leakag
apertur
eg
hole
filter
stapl
use
secur
ffr
strap
numer
workplac
studi
shown
properli
fit
nioshcertifi
ffr
reduc
toxic
inhal
exposur
factor
control
leak
studi
conduct
use
manikin
headform
shown
leak
size
domin
factor
affect
respir
inward
leakag
workplac
oshamand
fit
test
requir
ensur
respir
capabl
fit
healthcar
worker
ie
seal
tightli
face
minim
leakag
face
seal
area
ffr
seal
ie
perfect
fit
experi
captur
effici
viabl
influenza
exceed
lowest
flow
rate
repres
bestcas
scenario
term
fit
howev
inward
leakag
routin
respir
wear
factor
data
combin
workplac
studi
cite
suggest
ffr
capabl
reduc
inhal
exposur
influenza
infecti
aerosol
factor
greater
properli
fit
use
expect
similar
attenu
workplac
aerosol
conclus
studi
empir
demonstr
nioshapprov
ffr
captur
viabl
influenza
aerosol
effici
equal
greater
rate
suggest
properli
fit
ffr
reduc
inhal
exposur
airborn
influenza
viru
ffr
model
test
part
studi
find
broad
applic
properli
fit
nioshapprov
ffr
studi
also
demonstr
ffr
model
test
remov
particl
airstream
indiscrimin
viabil
particl
contain
influenza
equal
affect
filtrat
mechan
inert
particl
size
although
antimicrobi
ffr
demonstr
significantli
higher
vfe
also
show
significantli
higher
pfe
thu
enhanc
perform
must
attribut
physic
mean
rather
antimicrobi
activ
financi
support
research
fund
biomed
advanc
research
develop
author
offic
assist
secretari
prepared
respons
us
depart
health
human
servic
interag
agreement
air
forc
research
laboratori
afrl
work
also
partli
fund
nation
institut
occup
safeti
health
interag
agreement
afrl
repres
fund
agenc
involv
develop
experiment
design
data
interpret
manuscript
prepar
laboratoryscal
aerosol
tunnel
ffr
filter
facepiec
respir
hepa
higheffici
particul
air
data
filter
facepiec
respir
ffr
replic
detect
limit
infect
control
hosp
epidemiol
author
manuscript
avail
pmc
novemb
